About the Project

Disease Control Priorities Network (DCPN), funded in 2009 by the Bill & Melinda Gates Foundation, is a seven year project managed by University of Washington’s Department of Global Health (UW-DGH) and the Institute for Health Metrics and Evaluation (IHME). UW-DGH leads and coordinates two key components to promote and support the use of economic evaluation for priority setting at both global and national levels.

Disease Control Priorities, 3rd edition

UW-DGH coordinates and manages the production of the 3rd Edition of the evidence Disease Control Priorities (DCP3).   Building on its predecessors, DCP1 (1993) and DCP2 (2006) published for the World Bank by Oxford University Press, the third edition will provide the most up to date evidence on intervention efficacy and program effectiveness for the leading causes of global disease burden.  It will go beyond previous efforts by providing systematic economic evaluation of policy choices affecting the access, uptake, and quality of interventions and delivery platforms for low-and middle-income countries.  DCP3 will introduce new extended cost-effectiveness analysis methods for assessing the equity and financial protection considerations of health and macroeconomic policies for extending coverage of proven effective interventions to prevent and treat infectious and chronic diseases, including conditions related to environmental health, trauma and mental disorders.  The Series Editors of DCP3 are Dean Jamison, Hellen GelbandSue HortonPrabhat Jha, Ramanan LaxminarayanRachel Nugent, and Charlie Mock. Draft chapters of DCP3 will be available on this website beginning in mid-2013 and complete volumes will be published electronically and in hard copy between 2015 and 2017.

Strengthening the capacity of evidence based decision-making

UW-DGH is working with global, regional and national partners in Sub-Saharan Africa, Latin America, China and the Middle East to conduct economic evaluation of the prevention and treatment of the most pressing conditions and diseases contributing to the global burden of disease through training workshops and collaborative research. Together, these components will provide the most comprehensive and up-to-date economic information to guide regional and national level policymaking, along with improved economic tools and more dispersed capacity for evidence-based priority-setting for health.